Report
Luis Arredondo
EUR 50.00 For Business Accounts Only

ROVI: MODERNA MAY SELL ITS COVID VACCINE TO CHINA (ANÁLISIS BANCO SABADELL)

According to the press, Moderna would have held talks with the Chinese Govt. regarding the possibility of supplying the country with its Covid-19 vaccine. The company’s CEO, Stephane Bancel, would have stated that the company has the supply capacity, but it has not yet made a decision on the matter.
Underlying
Laboratorios Farmaceuticos Rovi S.A.

Laboratorios Farmaceuticos Rovi is engaged in the sale of its own pharmaceutical products and the distribution of other products for which it holds licenses granted by other laboratories for specific periods, in accordance with the terms and conditions contained in the agreements entered into with said laboratories.

Provider
Sabadell
Sabadell

Analysts
Luis Arredondo

Other Reports on these Companies
Other Reports from Sabadell

ResearchPool Subscriptions

Get the most out of your insights

Get in touch